Andrew Hykes Inari Medical, Inc. (NARI) insider trading activity

Andrew Hykes is President and CEO of Inari Medical, Inc.. Currently has a direct ownership of 0 shares of NARI, which is worth approximately $0. The most recent transaction as insider was on Oct 19, 2021, when has been sold 9,000 shares (Common Stock) at a price of $87.49 per share, resulting in proceeds of $787,410. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0

0% 3M change

100.0% 12M change

Total Value Held $0

Andrew Hykes Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Oct 19 2021	SELL Open market or private sale	$787,410 $87.49 p/Share	9,000 Reduced 5.33%	159,827 Common Stock
Oct 01 2021	SELL Payment of exercise price or tax liability	$27,309 $78.7 p/Share	347 Reduced 0.21%	168,827 Common Stock
Sep 17 2021	SELL Open market or private sale	$728,010 $80.89 p/Share	9,000 Reduced 5.05%	169,174 Common Stock
Aug 19 2021	SELL Open market or private sale	$655,110 $72.79 p/Share	9,000 Reduced 4.81%	178,174 Common Stock
Aug 18 2021	BUY Exercise of conversion of derivative security	$8,600 $0.43 p/Share	20,000 Added 9.17%	198,174 Common Stock
Jul 19 2021	SELL Open market or private sale	$767,520 $85.28 p/Share	9,000 Reduced 4.59%	187,174 Common Stock
Jul 06 2021	SELL Payment of exercise price or tax liability	$33,309 $95.99 p/Share	347 Reduced 0.18%	196,174 Common Stock
Jun 21 2021	SELL Open market or private sale	$91,501 $91.41 p/Share	1,001 Reduced 0.49%	203,710 Common Stock
Jun 18 2021	SELL Open market or private sale	$734,708 $91.85 p/Share	7,999 Reduced 3.91%	196,611 Common Stock
May 20 2021	BUY Exercise of conversion of derivative security	$4,300 $0.43 p/Share	10,000 Added 4.64%	205,611 Common Stock
May 19 2021	SELL Open market or private sale	$743,220 $82.58 p/Share	9,000 Reduced 4.4%	195,611 Common Stock
Apr 19 2021	SELL Open market or private sale	$929,340 $103.26 p/Share	9,000 Reduced 4.21%	204,611 Common Stock
Apr 01 2021	SELL Payment of exercise price or tax liability	$39,316 $109.21 p/Share	360 Reduced 0.17%	213,611 Common Stock
Mar 19 2021	SELL Open market or private sale	$983,700 $109.3 p/Share	9,000 Reduced 4.04%	213,971 Common Stock
Mar 17 2021	BUY Exercise of conversion of derivative security	$8,600 $0.43 p/Share	20,000 Added 8.23%	222,971 Common Stock
Feb 19 2021	SELL Open market or private sale	$1,056,960 $117.44 p/Share	9,000 Reduced 4.25%	202,971 Common Stock
Feb 11 2021	BUY Grant, award, or other acquisition	-	16,030 Added 7.03%	211,971 Common Stock
Jan 19 2021	SELL Open market or private sale	$869,400 $96.6 p/Share	9,000 Reduced 4.39%	195,941 Common Stock
Jan 13 2021	SELL Open market or private sale	$2,640,216 $95.66 p/Share	27,600 Reduced 11.87%	204,941 Common Stock
Jan 05 2021	SELL Open market or private sale	$2,220,144 $80.44 p/Share	27,600 Reduced 10.61%	232,541 Common Stock
Dec 18 2020	SELL Open market or private sale	$1,941,016 $70.84 p/Share	27,400 Reduced 9.53%	260,141 Common Stock
Nov 30 2020	SELL Open market or private sale	$1,845,938 $67.37 p/Share	27,400 Reduced 8.7%	287,541 Common Stock

Andrew Hykes

President and CEO

Irvine, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells NARI shares.

Notify only if

Value

Insider Trading

Get notified when an Inari Medical, Inc. insider buys or sells NARI shares.

Notify only if

Operation

Value

Type

News

Receive news related to Inari Medical, Inc.

Track Activities on NARI

Account